Gastrointestinal/Hepatobiliary Oncology Program
The Gastrointestinal Tumor Study Group meets on a weekly basis to address clinical and research issues relating to all types of GI malignancies. At this meeting, treatment and patient care issues are presented to assure that the full spectrum of cancer prevention, diagnosis, treatment and follow-up options are appropriately considered for every patient. The program integrates a spectrum of clinical, basic, and translational research activities, assuring close collaboration between basic scientists and clinicians for the rapid translation of research discoveries to clinical care and to enlist the assistance of basic researchers in solving clinical problems. The clinical arm of the program provides interdisciplinary diagnostic and treatment modalities that include prevention in high risk populations, early diagnosis, therapeutic evaluations, multi-disciplinary management of patients with cancer and pre-cancerous conditions, and treatment of advanced disease. The program strives to make new prevention, diagnostic, and treatment approaches available to patients through institutional, regional and national clinical protocols. Useful Links From The Resource and Learning Center: Bladder Cancer Staff of this Program: |
Pediatric Hematology/Oncology Program
Adult Oncology Program
Breast Oncology - Stacy Goldstein Breast Cancer Center Gastrointestinal/Hepatobiliary Oncology Program Genetic Counseling and Risk Assessment/The LIFE Center Leukemia/Lymphoma/Hematologic Malignancies Liver Cancer and Bile Duct Cancer Care Program Melanoma and Soft Tissue Oncology Program Phase I/Developmental Therapeutics Prostate Cancer: Dean and Betty Gallo Prostate Cancer Center Stem Cell Transplantation Program
|
The Gastrointestinal/Hepatobiliary Oncology Program of The Cancer Institute of New Jersey is a multidisciplinary clinical and scientific program that provides comprehensive services to patients with pre-cancerous and cancerous conditions involving the esophagus, stomach, small intestines, colon, rectum, pancreas, biliary tract, liver, retroperitoneum, and other intra-abdominal organs. The program emphasizes the comprehensive evaluation of patients under one roof with a close collaboration of multiple specialists including surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, radiologists, pathologists, nurses, pharmacists and social workers.